Medicaid VBPs for Patients Act

Bill: 118-hr-2666
Sponsor: Rep. Guthrie, Brett [R-KY-2]
Introduced: 2023-04-18 in the House
Policy area: Health
Subjects: Administrative law and regulatory procedures
Congressional oversight
Department of Health and Human Services
Government studies and investigations
Health care costs and insurance
Intergovernmental relations
Medicaid
Prescription drugs

Summary:
action_date: 2023-04-18
text: 

Medicaid VBPs for Patients Act or the MVP Act

 
This bill provides statutory authority for regulations that allow for the use of varying best price points under value-based purchasing arrangements for purposes of the Medicaid Drug Rebate Program. (
Value-based purchasing arrangements 
refer to arrangements in which the price of a drug is linked to clinical outcomes; such arrangements are particularly used for new high-cost treatments, such as gene therapies.)
 
The Government Accountability Office must study the impact of value-based purchasing arrangements on federal health care programs, including with respect to the bill's changes.
 
Additionally, the bill (1) exempts sales of drugs that are made under value-based purchasing arrangements from calculations of the manufacturer average sales price for purposes of payments under Medicare medical services, if the manufacturer reports multiple best prices under Medicaid in accordance with the bill's changes; and (2) requires the Centers for Medicare & Medicaid Services to establish a program under which state Medicaid programs may cover drugs in inpatient settings via value-based purchasing arrangements.
 
The bill's changes terminate five years after enactment; any value-based purchasing arrangements that are in effect as of the date of termination continue to apply.


Legislative actions:
action_date: 2024-12-19
text: Placed on the Union Calendar, Calendar No. 768.
action_date: 2024-12-19
text: Committee on Ways and Means discharged.
action_date: 2024-12-19
text: Committee on Ways and Means discharged.
action_date: 2024-12-17
text: Referred to the Subcommittee on Work and Welfare.
action_date: 2024-11-18
text: House Committee on Ways and Means Granted an extension for further consideration ending not later than Dec. 19, 2024.
action_date: 2024-11-18
text: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-743, Part I.
action_date: 2024-11-18
text: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-743, Part I.
action_date: 2023-05-24
text: Ordered to be Reported (Amended) by the Yeas and Nays: 31 - 19.
action_date: 2023-05-24
text: Committee Consideration and Mark-up Session Held.
action_date: 2023-05-17
text: Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 16 - 11 .
action_date: 2023-05-17
text: Subcommittee Consideration and Mark-up Session Held.
action_date: 2023-05-15
text: Referred to the Subcommittee on Health.
action_date: 2023-04-18
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2023-04-18
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2023-04-18
text: Introduced in House
action_date: 2023-04-18
text: Introduced in House